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Abstract: Sensory primary afferent fibers, conveying touch, pain, itch, and proprioception, synapse
onto spinal cord dorsal horn neurons. Primary afferent central terminals express a wide variety of
receptors that modulate glutamate and peptide release. Regulation of the amount and timing of
neurotransmitter release critically affects the integration of postsynaptic responses and the coding
of sensory information. The role of GABA (γ-aminobutyric acid) receptors expressed on afferent
central terminals is particularly important in sensory processing, both in physiological conditions
and in sensitized states induced by chronic pain. During the last decade, techniques of opto- and
chemogenetic stimulation and neuronal selective labeling have provided interesting insights on
this topic. This review focused on the recent advances about the modulatory effects of presynaptic
GABAergic receptors in spinal cord dorsal horn and the neural circuits involved in these mechanisms.
Keywords: sensory transmission; dorsal horn; presynaptic inhibition; GABA
1. Introduction
The spinal cord dorsal horn represents the principal station where primary afferent
fibers (PAFs) terminate, carrying information about several somatic sensory modalities.
Primary afferent fibers transmitting pain, touch, itch, and proprioceptive inputs project
to different dorsal horn laminae (laminae I–VI) (Figure 1), synapsing onto excitatory and
inhibitory interneurons and projection neurons. PAFs belong to different categories (Aα,
Aβ, Aδ, and C) that convey distinct sensory modalities. In particular, the fiber groups
relevant to this review include: (1) myelinated Aβ and low threshold (LT) Aδ fibers,
mediating innocuous mechanical sensitivity, and mainly projecting to lamina II inner, III,
and IV; (2) high threshold (HT) myelinated Aδ and unmyelinated C fibers, mediating pain,
thermal sensations, and itch, and mainly terminating in lamina I and II. Some nociceptive
and tactile inputs also reach lamina V, where they converge on wide dynamic range neurons.
Muscle afferent fibers were not considered in this review.
The variety of neurons in the spinal cord makes the investigation of dorsal horn
circuits difficult. Based on the expression of distinct neurochemical markers, several classes
of neurons have been identified in rodent lamina I, II, and III of the dorsal horn, exhibit-
ing different morphologies and functional properties [1–4]. The transgenic expression of
fluorescent proteins, such as EGFP or tdTomato, driven by a cell-type-specific promoter,
has allowed the characterization of morphological and electrophysiological properties of
specific neuron populations. Glutamatergic excitatory interneurons, involved in pain and
touch transmission, include neurons expressing somatostatin (SOM+), cholecystokinin
(CCK+), calretinin (CR+), protein kinase C gamma (PKCγ+), and vesicular glutamate
transporter 3 (vGlut3+). GABAergic and glycinergic inhibitory interneurons include neu-
rons expressing parvalbumin (PV+), dynorphin (DYN+), galanin (partially overlapping
with DYN+), neuronal nitric oxide synthase (nNOS+), and early expressed tyrosin kinase
receptor RET (early RET+, partially overlapping with PV+). Nociceptive projection neurons
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are mostly located in lamina I and relay sensory information to the brain stem and the
thalamus. A subpopulation of these neurons expresses the neurokinin receptor NK1.
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neurons are located in lamina I (black circles), while wide dynamic range neurons (orange circles), 
activated by both tactile and nociceptive stimuli, are localized in lamina V. Muscle afferent fibers 
(Aα) are not considered in this diagram. 
Primary afferent terminals release primarily glutamate onto dorsal horn neurons. A 
subclass of Aδ and C fibers also contains peptides, such as Substance P or CGRP, and/or 
neurotrophic factors (BDNF, GDNF). 
The “first synapse” in dorsal horn represents the first opportunity to modify sensory 
information entering the spinal cord and it is subjected to a very complex and fine modu-
lation. Numerous ion channels and ligand-gated receptors are involved in the modulation 
of glutamate and peptide release from PAFs, thereby controlling the impact of sensory 
input on second order neurons. In this review, we will present some recent studies about 
GABA-mediated presynaptic modulation at the first synapse in spinal cord dorsal horn, 
focusing on the neural circuits involved. 
2. GABAergic Inhibition on Primary Afferent Fibers 
GABAergic interneurons play a critical role in regulating nociceptive signal strength 
and separating nociception from touch. Intrathecal application of bicuculline and strych-
nine (antagonists of GABAA and glycine receptors, respectively) increases responses 
evoked by exposure to noxious stimuli [5]. According to the gate theory of pain, proposed 
by Melzack and Wall [6], stimulation of Aβ fibers activate inhibitory interneurons in the 
dorsal horn, “closing the gate” to nociceptive transmission. Conditions of disinhibition 
(either pharmacological or induced by persistent pain) “open the gate”, increasing pain 
response and causing allodynia (i.e., the perception of an innocuous stimulus as noxious). 
Presynaptic GABA receptors located on PAF terminals are involved in gating both 
tactile and noxious stimuli in the dorsal horn. Indeed, GABA receptors of the A and B type 
are expressed on both nociceptive and non-nociceptive PAFs, where axo-axonic synapses 
have been described. 
GABAA receptors (GABAARs) are ligand-gated heteropentameric ion channels, most 
commonly formed by 2α, 2β, and 1γ subunit. The composition of GABAARs on PAFs is 
heterogeneous: C fibers express the α2, α3, and α5 subunits, while α1, α2, α3, and α5 are 
present on myelinated A fiber terminals [7–9]. The subunit β3 has been shown as the dom-
inant β subunit expressed in dorsal root ganglion (DRG) neurons of both A and C type: In 
Figure 1. Organization of primary afferent fibers projecting to spinal cord dorsal horn. Nociceptive
fibers terminate mainly in superficial dorsal horn (laminae I–II), while tactile afferents (Aβ and
LT (low threshold) Aδ) project mainly to deep dorsal horn (laminae III–V). Nociceptive projection
neurons are located in lamina I (black circles), while wide dynamic range neurons (orange circles),
activated by both tactile a d nociceptive stimuli, are localized in lamina V. Muscle afferent fibers
(Aα) are not considered in this diagram.
Primary afferent terminals release primarily glutamate onto dorsal horn neurons. A
subclass of Aδ and C fibers also contains peptides, such as Substance P or CGRP, and/or
neurotrophic factors (BDNF, GDNF).
The “first synapse” in dorsal horn represents the first opportunity to modify sensory
information entering the spinal cord and it is subjected to a very complex and fine modula-
tion. Numerous ion channels and ligand-gated receptors are involved in the modulation
of glutamate and peptide release from PAFs, thereby controlling the impact of sensory
input on second order neurons. In this review, we will present some recent studies about
GABA-mediated presynaptic modulation at the first synapse in spinal cord dorsal horn,
focusing on the neural circuits involved.
2. GABAergic Inhibition on Primary Afferent Fibers
GABAergic interneurons play a critical role in regulating nociceptive signal strength
and separating nociception from touch. Intrathecal application of bicuculline and strych-
nine (antagonists of GABAA and glycine receptors, respectively) increases responses
evoked by exposure to noxious stimuli [5]. According to the gate theory of pain, pro-
posed by Melzack and Wall [6], stimulation of Aβ fibers activate inhibitory interneurons in
the dorsal horn, “closing the gate” to nociceptive transmission. Conditions of disinhibition
(either pharmacological or induced by persistent pain) “open the gate”, increasing pain
response and causing allodynia (i.e., the perception of an innocuous stimulus as noxious).
Presynaptic GABA receptors located on PAF terminals are involved in gating both
tactile and noxious stimuli in the dorsal horn. Indeed, GABA receptors of the A and B type
are expressed on both nociceptive and non-nociceptive PAFs, where axo-axonic synapses
have be n described.
GABAA receptors (GABAA s) are ligand-gated heteropentameric ion chan els, most
commonly formed by 2α, 2 , he co position of GABAARs on PAFs
is heterogeneous: C fibers express the α2, α3, and α5 subunits, while α1, α2, α3, and α5
are present on myelinated A fib terminals [7–9]. The subunit β3 has been shown as the
dominant β subunit expr ssed in dorsal root ganglion (DRG) neurons of both A and C type:
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In a mouse line where the β3 subunit is selectively knocked out in primary nociceptors,
the GABA current in DRG neurons is decreased and the animals exhibit hypersensitivity to
noxious heat and mechanical stimulation [10].
2.1. Primary Afferent Depolarization
Presynaptic GABAARs expressed on PAF terminals mediate primary afferent depolar-
ization (PAD) in spinal cord dorsal horn. This phenomenon, firstly described in muscle
afferents [11], consists of a slow dorsal root depolarization, evoked by the stimulation of
an adjacent root. Stimulation of PAFs evokes glutamate release that activates GABAergic
interneurons. These neurons, in turn, release GABA binding to GABAARs expressed on
PAF terminals.
The cellular mechanisms of PAD have been extensively investigated. Primary sensory
neurons exhibit a higher intracellular concentration of chloride than most central neurons.
This is caused by the high expression of the transporter NKCC1 (transporting Cl−, Na+
and K+ into the cell) and the low, or even undetectable, expression of KCC2 (expelling Cl−
and K+ out of the cell) [12–16]. Due to the high Cl− intracellular concentration, the chloride
equilibrium potential (ECl) in DRG neurons is about −30 mV [13,17]. Thus, the activation
of GABAARs on PAF terminals produces an outward anion flux, leading to membrane
depolarization and generation of PAD.
In physiological conditions, PAD exerts an inhibitory effect on glutamate release,
through several possible mechanisms. PAF depolarization can lead to the inactivation of
voltage-dependent Na+ and Ca+ channels, impairing the propagation of action potentials
along PAFs and decreasing the calcium influx into the terminals [18–22]. The opening of
GABAA channels could also exert a shunting effect on action potential propagation by
decreasing membrane resistivity, as shown by experimental evidence and mathematical
simulations [23–26]. Suprathreshold PAF depolarizations can sometimes trigger action
potentials that are conducted antidromically, generating dorsal root reflexes [27,28].
Earlier studies have demonstrated the involvement of GABAARs in the generation of
PAD: The GABAA antagonist picrotoxin blocks presynaptic inhibition on spinal monosy-
naptic reflexes, while iontophoretic application of GABA generates depolarization of
group I afferent fibers [29,30]. More recently, Witschi et al. have shown that mice lacking
the GABAA α2 subunit specifically in primary nociceptors exhibit a lack of effect of the
GABAA modulator diazepam in potentiating PAD and decreasing inflammatory hyper-
algesia, confirming the involvement of presynaptic GABAARs in PAD generation and
pain inhibition [31]. Interestingly, neither glycine receptors nor gephyrin clusters have
been detected on C fibers expressing GABAARs, in contrast with inhibitory synapses on
postsynaptic neurons [8]. The presence of unclustered GABAARs on presynaptic termi-
nals suggests a more diffuse mode of inhibition at these synapses, consistent with the
slow kinetics of GABA-mediated PAD. Beside GABAARs, also glutamatergic receptors of
the AMPA and NMDA type, expressed on PAF central terminals, have been reported to
contribute to the generation of PAD in the spinal cord [32].
PAD has been proposed as one of the most powerful mechanisms of sensory control,
producing several effects: (1) reduction in the effectiveness of one sensory input over the
others and selective control of convergent inputs; (2) generation of surround inhibition,
producing localized reactions to sensory stimuli (a small stimulus to the skin produces PAD
in the same spinal cord segment, but also in many rostral and caudal segments, both ipsi-
and contra-lateral); and (3) increase of the temporal contrast of a somatic sensory input.
Accordingly, PAD mediated by GABAARs is composed of a phasic and a tonic component
(likely mediated by receptors expressing the α5 subunit [33]): The first increases the
perception of a sudden stimulus, while the latter represents the ongoing inhibition of slow
changes of sensory inputs.
The functional properties of PAD in muscle afferents and LT cutaneous PAFs have been
investigated by several studies [20,27,34,35]. We recently demonstrated that presynaptic
GABAARs are involved in short term synaptic depression during repetitive stimulation of
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Aβ fibers [36] (Figure 2). We performed electrophysiological experiments on rat spinal cord
slices, recording from unidentified laminae III–IV neurons, in voltage-clamp at −70 mV.
The dorsal root attached to the slice was electrically stimulated with four pulses at the
frequency of 10–20 Hz and intensity of 10–25 µA, recruiting LT A fibers, mainly of the Aβ
type. The evoked excitatory postsynaptic currents (EPSCs) showed a strong depression
after the first response, which was particularly evident in the second EPSC (Figure 2B,
black trace). Application of the GABAA antagonist gabazine unmasked an additional
component in the second EPSC (blue trace): This indicates that GABA, released after the
first pulse, acts on presynaptic GABAARs, reducing glutamate release from Aβ fibers at the
second stimulus. By mainly affecting the second response in a train of stimuli, presynaptic
GABAARs inhibit glutamate release from PAFs with a high temporal precision, controlling
the earliest part of an afferent response to touch
Using a cesium-fluoride intracellular solution, able to block GABAARs expressed on
the recorded neuron, the effect of gabazine on the second EPSC was not abolished, confirm-
ing the involvement of presynaptic GABAARs. Application of strychnine was ineffective in
increasing the second EPSC, indicating that glycine receptors are not importantly involved
in presynaptic modulation on PAF terminals. By recording at −10 mV from laminae III–
IV neurons and stimulating at Aβ fiber threshold, we observed inhibitory postsynaptic
currents, mediated by both GABAA and glycine receptors. Thus, GABAARs modulate the
first synapse between Aβ fibers and dorsal horn neurons in two ways: through a negative
feedback mechanism at PAF terminals and by a feed-forward control on postsynaptic
neurons.
Differently from LT afferent fibers, functional studies about PAD on HT nociceptive
fibers are still limited. By using an ex vivo spinal cord preparation, Fernandes et al. [37]
recently reported that noxious C-fiber input to rat lamina I neurons (both projection and
local neurons) is presynaptically modulated by Aβ, Aδ, and C fibers. Thus, presynaptic
inhibition mediated by these different groups of afferents may control the inflow of noci-
ceptive input to superficial dorsal horn, playing a role in nociceptive discrimination and
lateral inhibition.
2.2. GABAB Receptors as Presynaptic Modulators
In addition to GABAA, activation of GABAB receptors (GABABRs), expressed on
nociceptive and non-nociceptive PAF terminals, also contributes to presynaptic inhibition,
exerting analgesic and anti-hyperalgesic effects [38]. GABABRs are G protein-coupled re-
ceptors, expressed as obligate heterodimers of the two subunits GABAB1 and GABAB2. The
GABAB1 isoforms 1a and 1b, together with the subunit GABAB2, have been found in small
and large DRG neurons and in the spinal cord, both at PAF terminals and on dorsal horn
neurons [39–41]. Endogenous or exogenous activation of GABABRs in superficial dorsal
horn causes both pre- and postsynaptic effects. Electrophysiological studies performed
on rats have shown that presynaptic GABABRs inhibit pinch- and touch-evoked synaptic
responses in vivo [42] and decrease glutamate and peptide release from A- and C-type
PAFs and dorsal horn neurons [40,43–46]. The inhibitory effect of GABABRs on transmitter
release is due to the concurrent inhibition of presynaptic calcium channels [47,48] and
release machinery downstream of calcium entry into the nerve terminals [49].
By performing electrophysiological experiments similar to those described above,
we showed that the block of GABABRs increases the first EPSC in a train of four stimuli,
recorded from lamina III–IV neurons [41] (Figure 2C, red trace). This suggests that, dif-
ferently from GABAARs, which require the release of GABA through synaptic activation,
GABABRs are tonically activated, confirming the finding of a previous study performed in
lamina II [50].
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tion of the GABAAR antagonist gabazine (10 μM) increased the second EPSC (blue trace, arrow) in 
10 out of 17 recorded neurons. (C) Representative traces of EPSCs, evoked by stimulating LT A 
fibers with four pulses at 20 Hz. In the presence of the GABAB antagonist CGP 55,845 (5 μM), the 
first EPSC increased in five out of 13 lamina III–IV neurons (red trace, arrow). Modified with per-
mission from [41]. 
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Figure 2. Presynaptic modulation mediated by GAB A and GABAB receptors on low threshold (LT)
A fibers in deep dorsal horn (laminae III–IV). (A) Schematic repres ntation of the circuit activating
presynaptic GABA receptors. GAB A rec ptors can be recruited by a s ti : an
inhibitory interneuron (I ) is activated by LT fibers and releases B onto fibers of the same
type, causing the inhibition of glutamate release and synaptic depression. GABABRs (GABAB
receptors) can tonically inhibit the release of glutamate from LT fibers. (B) Representative traces of
EPSCs recorded from a lamina III–IV neuron, evoked by stimulating LT fibers with four pulses at
10 Hz. A strong depression of the second response was evident in control (black trace). Application
of the GABAAR antagonist gabazine (10 µM) increased the second EPSC (blue trace, arrow) in 10
out of 17 recorded neurons. (C) Representative traces of EPSCs, evoked by stimulating LT A fibers
with four pulses at 20 Hz. In the presence of the GABAB antagonist CGP 55,845 (5 µM), the first
EPSC increased in five out of 13 lamina III–IV neurons (red trace, arrow). Modified with permission
from [41].
3. Dorsal Horn Circuits Involved in GABAergic Presynaptic Inhibition
The majority of inputs to PAF central terminals are represented by local neurons.
Axo-axonic synapses formed by GABAergic interneurons onto PAF terminals have been
detected on both muscle and cutaneous PAFs [2,20]. Some of these synapses are localized
in complex synaptic structures named glomeruli [51], containing central projections of
PAFs, GABAergic axo-axonic inputs, and likely also dendro-axonic synaptic inputs. PAD
is believed to be originated at GABAergic axo-axonic synapses onto PAFs, but also at
extrasynaptic sites, where GABA could diffuse by volume transmission from synapses or
en passant varicosities located near PAF terminals [52].
3.1. Presynaptic Inhibition of Tactile Stimuli
The nature of some of the GABAergic interneurons mediating PAD has been high-
lighted by recent studies. In particular, parvalbumin (PV+) neurons located in mouse
lamina II inner or lamina III form numerous axo-axonic synapses onto VGlut1 (Vesicular
glutamate transporter 1) expressing myelinated PAFs (including LT mechanoreceptors and
non-nociceptive Aδ down-hair afferents), both at glomerular and non-glomerular com-
plexes [53]. As shown by Boyle et al. [54], opto-stimulation of PV+ neurons prior to dorsal
root electrical stimulation causes a time-dependent reduction of the amplitude of evoked
EPSCs recorded from dorsal horn neurons, confirming the involvement of PV+ neurons
in presynaptic inhibition. PV+ neurons receive monosynaptic inputs from LT myelinated
fibers and form inhibitory synapses also with dorsal horn excitatory interneurons, such
as PKCγ+, that convey nociceptive information to projection neurons [55]. So, according
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to the gate theory of pain, PV+ neurons provide in normal conditions a powerful inhibi-
tion of excitatory interneurons, preventing innocuous mechanical input from activating
nociceptive mechanical circuits [54,55] (Figure 3).
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Figure 3. Schematic representation of neural circuits involved in GABAergic presynaptic inhibition in
dorsal horn. (1) Parvalbumin-positive neurons (PV+) receive low threshold tactile inputs and inhibit
both A fiber terminals and some p pulations of excitatory in erneurons (EX) ( uch as protein kinase
C gamma neurons, PKCγ+), connected (directly or indirectly) to nociceptive projection neurons (PN).
Loss of activity of PV+ determines the activation of the excitatory interneurons by tactile stimuli
and their transmission to nociceptive PNs, generating mechanical allodynia [54,55]. (2) A disynaptic
circuit could also be involved in A fiber inhibition, by recruiting an excitatory interneuron (possibly
cholecystokinin neuron, CCK+), and an unknown inhibitory interneuron [56]. 3. HT (high threshold)
nociceptive fibers are subjected to presynaptic inhibition by GABAergic interneurons. The nature
of these neurons is still not identified, although early RET+ neurons (expressing the tyrosin kinase
receptor RET in the early postnatal period) could be involved [57].
3.2. Presynaptic Modulation of Nociceptive Fibers
The nature of GABAergic interneurons mediating PAD on nociceptive fibers is still
largely unknown. Cui et al. [57] have characterized a population of dorsal horn inhibitory
neurons located in mouse deep dorsal horn (laminae III–IV), expressing neonatally the
tyrosine kinase receptor RET (early RET+). These neurons may receive inputs from both
A and C fibers and inhibit dorsal horn excitatory interneurons, such as PKCγ+ and SST+
(somatostatin expressing neurons). Early RET+ neurons make presynaptic inhibitory
synapses onto PAF terminals; their optogenetic activation inhibits Aβ or C fiber-mediated
responses in dorsal horn neurons, through the activation of presynaptic GABAB receptors.
This suggests that early RET+ neurons are involved in presynaptic inhibition of both pain
and touch, likely mediating the cross talk between the two sensory modalities.
An interesting and complex mechanism of presynaptic inhibition involving both
GABAA and NMDA receptors has been recently described by Zimmerman et al. [56]. In the
mouse ex vivo hemisected spinal cord preparation, optogenetic activation of distinct groups
of fibers produces three mechanisms of presynaptic inhibition: two homotypic, GABAA-
dependent modulations, where activation of LT tactile or HT nociceptive fibers evokes
PAD in fibers of the same type; one heterotypic, NMDA-dependent mechanism, evoked
by nociceptive stimulation and inhibiting tactile fibers. G BA- and NMDA-dependent
presynaptic inhibitions seem to be functionally distinct: They are exerted in different skin
regions and only the GABAA-dependent modulation is required for texture discrimination.
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4. GABA Release from Descending Fibers and Astrocytes
Although GABAergic interneurons seem to be the principal source of GABA for
presynaptic inhibition on PAFs, other possible sources of GABA have been described.
PAF terminals receive inputs from fibers descending from brain stem and hypothala-
mus, releasing different amines, such as serotonin, noradrenaline, and dopamine, involved
in presynaptic modulation [58–61]. A large proportion of fibers descending from the brain
stem rostral ventral medulla (RVM) are represented by descending GABAergic fibers, most
of which release also enkephalin. Opto-activation of dual GABAergic/enkephalinergic
RVM neurons evokes dorsal root potentials with short latencies in mouse cervical dorsal
roots, suggesting that these descending fibers provide functional and direct presynaptic
inputs to PAFs [62]. Ablation of GABAergic/enkephalinergic RVM neurons, by using a
Cre-dependent active caspase system, causes hypersensitivity to both heat and mechani-
cal stimuli, whereas chemogenetic activation of these neurons produces antinociception.
François et al. [63] characterized a group of GABAergic fibers originating in RVM, which
do not express enkephalin and form inhibitory synapses onto enkephalinergic interneurons
in the dorsal horn. Opto-stimulation of this descending pathway causes facilitation of
mechanical pain and could be involved in the mechanical hypersensitivity produced by
chronic stress.
A descending cortico-spinal system involved in sensory modulation has also been
described in rats [64]. This pathway, originating in the sensorimotor cortex, inhibits C-
fiber nociceptive responses through the activation of presynaptic GABAARs. Cortical
modulation of spinal cord sensory processing could be particularly important for motor
control: At the onset of voluntary movement this system would be involved in the selection
of sensory information, required for the correct execution of the motor task.
Dorsal horn astrocytes respond to nociceptive fibers’ stimulation with calcium oscilla-
tions [65] and can release several gliotransmitters, including glutamate and purines [66,67].
Recently, dorsal horn astrocytes in turtle spinal cord have been reported to release GABA in
response to glutamate application [68]. Interestingly, the time course of GABA release from
astrocytes is similar to the slow component of PAD generated by a non-spiking circuit [69],
suggesting that astrocytes could be involved in presynaptic inhibition of PAFs in normal
and/or pathological conditions.
5. Modifications of Presynaptic Inhibition in Chronic Pain
Persistent pain can be generated by a tissue or nerve injury, leading to inflammatory
or neuropathic pain, respectively. In both conditions sensitization to pain occurs, causing
hyperalgesia (the intensity of a noxious stimulus is increased) and allodynia (an innocuous
stimulus, mechanical or thermal, is perceived as painful).
A loss of inhibition mediated by GABA has been observed in both inflammatory
and neuropathic pain: As evidenced in several animal models of chronic pain, both pre-
and postsynaptic inhibitions become less efficient, leading the dorsal horn to a state of
hyperexcitability [4,70,71].
Several studies have shown that PAD is subjected to complex modifications in chronic
pain conditions. In inflammatory pain, a switch from presynaptic inhibition to excitation
has been reported: The amplitude of PAD is increased in both nociceptive and non-
nociceptive fibers after tissue injury, and this could be sufficient to generate action potential
firing at PAF terminals and dorsal root reflexes [27,72]. Orthodromically propagated
action potentials may enhance glutamate and peptide release from central nociceptive
terminals, causing excitation of spinal second order neurons [72,73]. Action potentials
propagated antidromically to the periphery have been involved in neurogenic inflammation
in experimental arthritis or after intradermal injection of capsaicin [74–76]. Changes of
chloride homeostasis and GABAAR activity in DRG neurons could be involved in the
increase of PAD amplitude observed after inflammation. Accordingly, inflammatory
mediators cause the increase of NKCC1 activity and intracellular chloride concentration in
DRG neurons in vitro [77], painful stimulation enhances phosphorylation and membrane
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mobilization of NKCC1 [78], and GABA sensitivity of DRG neurons is increased in a model
of inflammatory joint pain [79].
Following nerve injury, PAD amplitude is generally reduced and presynaptic inhi-
bition is diminished [70,71]. Several factors seem to contribute to PAD modifications in
neuropathic pain: (1) decrease of GABA synthesis, due to the reduced expression of the
GABA synthetizing enzyme GAD65 in dorsal horn inhibitory interneurons [8,80]; (2) in-
crease of NKCC1 expression and activity, causing a depolarizing shift of ECl [22,81,82];
and (3) reduction of GABAA conductance and downregulation of γ2, α2, and α1 subunits
on DRG neurons, observed after nerve ligation, chronic constriction, and crush nerve
injury [10,83–86]. Consistently, the selective downregulation of the α2 subunit in DRGs
worsens thermal and mechanical hypersensitivity in crush-injured animals and induces
pain hypersensitivity in sham animals, while upregulation of endogenous GABA alleviates
neuropathic pain [86].
A decreased activity of inhibitory circuits in dorsal horn has been correlated to the de-
velopment of mechanical allodynia in both inflammatory and neuropathic pain. Previous
studies have identified a dorsally directed excitatory polysynaptic pathway conveying tac-
tile input from LT PAFs to lamina I projection neurons [87,88]. In physiological conditions,
this pathway is inhibited by interneurons releasing GABA and glycine. In inflammatory
and neuropathic pain models, the efficacy of spinal inhibition is reduced and the tactile
input is allowed to reach the nociceptive projection neurons, causing allodynia. Duan
et al. [89] showed that inhibitory DYN+ neurons, receiving Aβ-mediated synaptic inputs,
play an important role in gating the tactile input to the excitatory SOM+ neurons in lamina
II. Selective ablation of DYN+ neurons (by using an intersectional genetic strategy leading
to the neuron-specific expression of the diphtheria toxin receptor) generates spontaneous
mechanical allodynia and Aβ fiber-mediated action potential firing in superficial dorsal
horn neurons. A more recent study [90] identified specific subpopulations of excitatory
interneurons involved in different forms of mechanical allodynia: By using chemogenetic
approaches, allowing the selective inhibition of different classes of neurons, the authors
demonstrated that CR+, CCK+, and V-Glut3+ neurons are involved in mechanical allodynia
in inflammatory models, while PKCγ+ (together with CCK+ and V-Glut3+) neurons are
critical for allodynia induced by nerve injury.
Alterations of presynaptic inhibition on LT A fibers could play an important role
in the genesis of mechanical allodynia. A reduction of GABA-mediated inhibition on
these fibers would cause the increase of glutamate release onto excitatory interneurons,
activating a relay circuit that conveys the tactile input to nociceptive projecting neurons
(Figure 3). Inhibitory PV+ neurons, forming axo-axonic synapses with LT A fibers, seem
to be importantly involved in this mechanism: Nerve injury reduces the excitability of
PV+ neurons, their chemogenetic activation significantly attenuates allodynia induced by
nerve injury, and saporin-mediated ablation of PV+ neurons induces a form of mechanical
allodynia that is PKCγ-dependent [55].
Although initially a neurodegenerative process had been proposed for the loss of
GABAergic inhibition in the dorsal horn in chronic pain, recent studies have shown that
nerve injury does not cause loss of PV+ neurons or changes in their synaptic connec-
tivity [54]. However, peripheral axotomy determines a reduction of excitability in PV+
neurons, and larger currents become necessary to elicit the sustained tonic action potential
discharge typical of these neurons. A decrease of the expression of PV, a calcium-buffering
protein, could contribute to this effect: The rise of intracellular calcium, subsequent to
PV decrease, could activate calcium-dependent potassium channels and prevent the fast
spiking activity in this neuron population [55]. A reduction in the excitatory drive from
Aβ fibers onto inhibitory neurons could also be responsible for the loss of presynaptic
inhibition observed in neuropathic pain models. Accordingly, a decrease of evoked and
miniature excitatory postsynaptic currents was observed in inhibitory interneurons after
injury [91].
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Changes of presynaptic inhibition on nociceptive fibers have been studied in less
detail. Specific ablation of early RET+ neurons, through injection of a Cre-dependent
virus expressing diphtheria toxin, increases basal nociception and leads to more severe
inflammatory and neuropathic pain, whereas opto-stimulation of these neurons produces
antinociception [57]. Further studies are required to determine whether modifications
in the activity of these or other inhibitory neurons affects presynaptic inhibition on HT
nociceptive fibers.
6. Conclusions and Future Perspectives
During the last decade substantial progress has been made in the characterization of
spinal cord dorsal horn circuits involved in sensory transmission. By combining advanced
techniques, such as genetic labeling, opto- and chemogenetic manipulation, and specific
neuronal ablation, several neuron populations have been characterized and their role in
sensory perception has been established. As described here, some of these neurons are
involved in presynaptic modulation of PAFs and changes in their functional properties
could contribute to the hyperalgesic and allodynic states related to chronic pain.
Despite these advances, many aspects need further investigation. Neuronal circuits
mediating presynaptic inhibition on PAFs are largely unknown, especially those modulat-
ing nociceptive fibers. More information is also needed about the modifications occurring
to these circuits after tissue or nerve injury. Furthermore, the interplay between different
presynaptic receptors on PAF central terminals is still not clear. Although many receptors
have been identified, both ionotropic and metabotropic, their role in acute nociception
and in states of pain sensitization is still not understood. NMDA receptors, for example,
are expressed on PAF terminals and could mediate PAD, but it is still not clear if they are
functional in normal conditions or become active only in pathological conditions [92].
The characterization of functional and pharmacological properties of presynaptic
receptors will be also important to develop more specific analgesic treatments. Recently, a
partial agonist at the benzodiazepine binding sites of GABAARs expressing the subunits
α2, α3, or α5 (particularly relevant for spinal analgesia) was tested in preclinical assays
and human studies [93,94]. Lacking activity at α1 GABAARs, this compound could exert
analgesic effects without the unwanted effects of classic benzodiazepines, such as sedation,
memory impairment, tolerance, and addiction.
GABABRs are also importantly involved in presynaptic inhibition in superficial dorsal
horn, exerting antinociceptive effects. The GABAB agonist baclofen is primarily used for
the treatment of severe spasticity, while its use as an analgesic drug is prevented by the
numerous side effects [95]. The development of positive allosteric modulators (PAMs),
which enhance the activity of GABABRs in the presence of endogenous or exogenous
orthosteric agonists, could represent a promising strategy [38]. While recently developed
PAMs (such as ADX71441) seem to exert significant antinociceptive activity in inflammatory
pain models by potentiating the endogenous activation of GABABRs [96], in neuropathic
animals the allosteric modulator rac-BHFF has no efficacy in increasing the endogenous
GABAB tone, but it might be useful to enhance baclofen-mediated analgesia at low baclofen
doses [97].
Finally, the role of glia, and especially of astrocytes, in dorsal horn sensory processing
is still poorly understood. As evidenced in several brain areas, gliotransmitters released by
astrocytes play a critical role in modulating neuronal activity, in both physiological and
pathological conditions. Future studies combining electrophysiology, calcium imaging,
and selective activation of dorsal horn astrocytes will be important to establish their role in
pre- and postsynaptic modulation of neuronal activity.
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